Cargando…
Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways
BACKGROUND: Experimental studies have demonstrated that both the extracellular vasculature or microenvironment and intracellular molecular network (e.g., epidermal growth factor receptor (EGFR) signaling pathway) are important for brain tumor growth. Additionally, some drugs have been developed to i...
Autores principales: | Liang, Weishan, Zheng, Yongjiang, Zhang, Ji, Sun, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509865/ https://www.ncbi.nlm.nih.gov/pubmed/31074391 http://dx.doi.org/10.1186/s12859-019-2737-1 |
Ejemplares similares
-
Multiscale modeling of drug resistance in glioblastoma with gene mutations and angiogenesis
por: Yang, Heng, et al.
Publicado: (2023) -
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010) -
Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019) -
Combined EGFR and VEGFR versus Single EGFR Signaling Pathways Inhibition Therapy for NSCLC: A Systematic Review and Meta-Analysis
por: Zhang, Xinji, et al.
Publicado: (2012) -
Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)